Subject: Collaboration on New Material Testing for IVF Devices

---

From: Nicholas Riddle <brentsingleton@example.org>  
To: Ethan Snyder <vickie73@example.net>  
Date: October 12, 2023, 9:15 AM  

Hi Ethan,

I hope this message finds you well. I'm reaching out to discuss the new biocompatible material we've been developing for our IVF devices. Given your expertise in embryology, your insights would be invaluable in assessing how these materials interact with gametes and embryos.

We've scheduled a preliminary round of testing next week in Lab 5B, and I wanted to ensure that the testing aligns with the clinical requirements. Could you provide your availability for a brief meeting this Friday to discuss your specifications and any potential concerns?

Additionally, we'll be using some of the new prototypes from the latest batch, and it would be great to have your input on any observations or adjustments needed to optimize performance.

Looking forward to your guidance.

Best regards,  
Nicholas Riddle  
Engineer, Materials  
Merck  
Phone: (732) 555-0199  

---

From: Ethan Snyder <vickie73@example.net>  
To: Nicholas Riddle <brentsingleton@example.org>  
Date: October 12, 2023, 11:30 AM  

Hi Nicholas,

Thanks for reaching out. The development of the new biocompatible material sounds promising, and I'm eager to see how it performs in a clinical setting. Iâ€™m available for a meeting this Friday at 2 PM. Let me know if that works for you.

In preparation, I'll compile some data on the typical interactions between the materials we've used in the past and the embryonic environment. This should provide a comparative framework for our discussion.

Also, please keep in mind that I'll be on leave starting October 23 for a week, so it would be ideal to wrap up any critical evaluations before then. If you need any immediate inputs post-testing, feel free to call me directly.

Looking forward to our collaboration on this.

Best,  
Ethan Snyder  
Embryologist, Clinical  
Merck  
Phone: (732) 555-0247  